Please login to your online account to display your discounted pricing

Promega™ Dual-Glo™ Luciferase Assay System

Generates both firefly and Renilla luciferase luminescence signals

$311.37 - $1,955.96

Specifications

Format 96 and 384-well Plates
Storage Requirements Store Dual-Glo Substrates at -20°C; store Dual-Glo Buffers below 25°C.
View More Specs
Includes:  Dual-Glo Luciferase Buffer; Dual-Glo Luciferase Substrate; Dual-Glo Stop & Glo™ Buffer; Dual-Glo Stop & Glo Substrate
Products
Catalog Number Mfr. No. Quantity Price Quantity    

PR-E2940

 
promega™
E2940
100mL Each for $1,955.96

PR-E2980

 
promega™
E2980
10 x 100mL CALL N/A N/A
 Please call Customer Service at 1-800-234-7437 or send an email to help@thermofisher.com for assistance.

PR-E2920

 
promega™
E2920
10mL Each for $311.37
Description & Specifications

Specifications

Format 96 and 384-well Plates
Storage Requirements Store Dual-Glo Substrates at -20°C; store Dual-Glo Buffers below 25°C.

Homogeneous reagent system enables fast and simple quantitation of stable luminescence from two reporter genes in a single sample. The activity of the primary reporter is correlated with the effect of specific stimuli and the activity of the co-transfected control reporter provides an internal control to normalize results.

  • Co-reporter minimizes effects of cell number, cell health, transfection efficiency, and nonspecific cellular responses
  • Cells may be assayed for both reporters directly in growth medium—no preconditioning or prelysing necessary
  • Stable signal may be measured for up to two hours after reagent addition—ideal for batch or continuous processing of 96- and 384-well plates
  • Two-step assay is suitable for any luminometer—no on-board injectors required
  • Linear range extends over at least six logs of enzyme concentration for each reporter

U.S. Patents 5,641,641; 5,650,289; and 5,814,471; Australian Patent 649289 and other patents.
U.S. Patent 5,744,320; Australian Patent 721172; Canadian Patent 2,221,522 and other patents.
U.S. Patents 7,078,181; 7,108,996; 7,118,878; Australian Patent 2001275325 and other patents pending.
The method of recombinant expression of Coleoptera luciferase is covered by U.S. Patents 5,583,024; 5,674,713; and 5,700,673.
Certain applications of this product may require licenses from others.
This product does not convey a license to use recombinant Renilla luciferase under U.S. Patent 5,418,155 and related patents. Promega sells licensed Renilla luciferase vectors, which may be used in conjunction with this product.